Trade Articles

Improving Preclinical Outcomes: De-Risking Your Drug Development Program

Preparing for Preclinical Testing: A Readiness Checklist

Managing critical reagents through drug development

Bioanalysis in the Age of New Drug Modalities

Analyzing FDA guidance on DDI studies for therapeutic proteins

5 questions drug developers need to ask when vetting laboratory testing partners

The opportunities and challenges inherent in using protein biomarkers for new drug development

Using In Vitro–In Vivo Extrapolation to Predict Human Clearance

The transition to ICH M10 and its impact on global submissions

Improving Submission Quality: Preparing For Regulatory Differences

Winning the drug development relay